Cargando…

Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics

In this US-based study of the National Cancer Database (NCDB), we examined 8550 patients diagnosed with non-metastatic, invasive inflammatory breast cancer (IBC) who received surgery from 2004–2013. Patients were grouped into four biologic subtypes (HR(+)/HER(2(−)), HR(+)/HER(2(+)), HR(−)/HER(2(+)),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biswas, Tithi, Jindal, Charulata, Fitzgerald, Timothy L., Efird, Jimmy T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339010/ https://www.ncbi.nlm.nih.gov/pubmed/30621221 http://dx.doi.org/10.3390/ijerph16010124

Ejemplares similares

The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer
por: Biswas, Tithi, et al.
Publicado: (2017)

On the Frontiers of Breast Cancer Diagnosis and Treatment: Current and Future Directions in a Rapidly Changing Field
por: Efird, Jimmy T., et al.
Publicado: (2022)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)

Breast Cancer Disparities in Asian Women: The Need for Disaggregated Research
por: Fane, Lauren, et al.
Publicado: (2022)

Cone beam computed tomography—the need for future guidance
por: Efird, Jimmy T., et al.
Publicado: (2022)

The Association between Age, Comorbidities and Use of Radiotherapy in Women with Breast Cancer: Implications for Survival
por: Efird, Jimmy T., et al.
Publicado: (2018)

Using a Counting Process Method to Impute Censored Follow-Up Time Data
por: Efird, Jimmy T., et al.
Publicado: (2018)

A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation
por: Kang, Kylie H., et al.
Publicado: (2021)

Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM phase III clinical trial
por: Biswas, Tithi, et al.
Publicado: (2021)

Trauma Affecting Asian-Pacific Islanders in the San Francisco Bay Area
por: Bith-Melander, Pollie, et al.
Publicado: (2017)

The evidence for Mycobacterium avium subspecies paratuberculosis (MAP) as a cause of nonsolar uveal melanoma: a narrative review
por: Pierce, Ellen S., et al.
Publicado: (2022)

Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Biswas, Tithi, et al.
Publicado: (2020)

US federal oversight of biological materials and the IBC
por: Howard, Deborah
Publicado: (2016)

Refugee Policy Implications of U.S. Immigration Medical Screenings: A New Era of Inadmissibility on Health-Related Grounds
por: Hong, Mi-Kyung, et al.
Publicado: (2017)

The Prevention and Management of COVID-19: Seeking a Practical and Timely Solution
por: Jindal, Charulata, et al.
Publicado: (2020)

Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women
por: Prasad, Shreya, et al.
Publicado: (2016)

Slow Burns: A Qualitative Study of Burn Pit and Toxic Exposures Among Military Veterans Serving in Afghanistan, Iraq and Throughout the Middle East
por: Bith-Melander, Pollie, et al.
Publicado: (2021)

Select agent program impact on the IBC
por: Adamovicz, Jeffery
Publicado: (2016)

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium
por: Devi, Gayathri R., et al.
Publicado: (2019)

Overcoming regulatory gaps in biological materials oversight by enhancing IBC protocol review
por: Rainer, David, et al.
Publicado: (2016)

A Pilot Study of Airborne Hazards and Other Toxic Exposures in Iraq War Veterans
por: Poisson, Chelsey, et al.
Publicado: (2020)

Strengthening the role of the IBC in the 21st century
por: Buller, R. Mark, et al.
Publicado: (2016)

IBCs – A cornerstone of public trust in research
por: Harris, Kathryn L., et al.
Publicado: (2016)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

Inflammatory breast cancer (IBC): clues for targeted therapies
por: Fernandez, Sandra V., et al.
Publicado: (2013)

Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption
por: de Assis, Leticia Ribeiro, et al.
Publicado: (2022)

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
por: Fouad, Tamer M., et al.
Publicado: (2018)

Race, insurance type, and stage of presentation among lung cancer patients
por: Efird, Jimmy T, et al.
Publicado: (2014)

Factors Associated with Discharge to a Skilled Nursing Facility after Transcatheter Aortic Valve Replacement Surgery
por: Horne, Carolyn E., et al.
Publicado: (2018)

Pathological complete response (pCR) with or without the residual intraductal carcinoma component following preoperative treatment for pancreatic cancer: Revisiting the definition of “pCR” from the prognostic standpoint
por: Yamada, Daisaku, et al.
Publicado: (2019)

Trapped in Statelessness: Rohingya Refugees in Bangladesh
por: Milton, Abul Hasnat, et al.
Publicado: (2017)

IBC – Proteomics, 1–2 March 2000, Basel Hilton, Switzerland
por: Masterson, Philip John
Publicado: (2001)

Intelligent Bayes Classifier (IBC) for ENT infection classification in hospital environment
por: Dutta, Ritaban, et al.
Publicado: (2006)

IBC CARe Microarray Allelic Population Prevalences in an American Indian Population
por: Best, Lyle G., et al.
Publicado: (2013)

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)
por: Gampenrieder, Simon Peter, et al.
Publicado: (2019)

Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens
Publicado: (1984)

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System
por: Hastedt, Jayne E., et al.
Publicado: (2022)

Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT)
por: Pu, Shengyu, et al.
Publicado: (2020)

Primary pulmonary lymphoepithelioma-like carcinoma: A case report of pathological complete response (pCR) by neoadjuvant treatment
por: Zhang, Liqin, et al.
Publicado: (2021)

Clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in postpartum women with breast cancer
por: Dou, He, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1a6d0g2dg24v95nqp11n82beq1